SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending due to its strategic shift towards quantum computing with potential applications in energy-efficient blockchain and cryptocurrency, drawing attention from investors. The community is actively discussing the implications of their laser-based processing unit (LPU) technology and its potential to disrupt the crypto and AI industries. Traders are also watching for news and potential partnerships related to its low float and threshold list status.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending due to increased interest in quantum computing stocks, spurred by news of a substantial investment in quantum technologies. The community is actively discussing the potential for a short squeeze and comparing RGTI to other quantum and AI-related stocks. High trading volume and positive market sentiment are contributing to the stock's upward momentum.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as part of a broader surge in quantum computing stocks, driven by increasing interest and speculation around government contracts and potential big tech partnerships. Community discussions revolve around the company's valuation, short squeeze potential, and its competitive position relative to other quantum firms like RGTI and IONQ. Some investors express concerns about a potential bubble, while others highlight D-Wave's technological advantages and growing real-world applications.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending due to a Jefferies downgrade, citing overly optimistic iPhone expectations, which has sparked debate among investors about its validity and impact. While some community members view the downgrade as an opportunity to buy, others express concern about Apple's valuation and potential risks related to tariffs. Broader discussions involve Apple's AI strategy, competition in the wearables market, and potential government shutdown impacts.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending following the announcement of a partnership with AI search engine Perplexity, aimed at enhancing video discovery on the platform. The community is buzzing about the potential impact of this collaboration, especially regarding AI-driven content recommendations and a new subscription bundle. Some traders speculate about a possible short squeeze, referencing the high short interest and significant call option activity.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending due to a planned $500 million private placement, sparking discussions about dilution and the company's growth prospects. Community members are debating the stock's valuation relative to its revenue and comparing it to other quantum computing stocks like IONQ and RGTI. Some traders are optimistic about the future of quantum computing and government support, while others express skepticism and highlight potential risks.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members highlight its unique position as the 'culture coin,' emphasizing freedom and growth. Some users are drawing comparisons to Bitcoin, while others promote its ties to cannabis culture. The community is also sharing links to the project's website, social media, and DEX Screener.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending after securing an $800,000 order for drone components from Red Cat, fueling discussions about drone dominance and the company's growth potential. While some community members question if the order size justifies the stock's reaction, others see it as a sign of more substantial contracts to come, especially with increasing government and defense sector interest in drone technology. The community is also closely watching for further developments and partnerships within the drone sector.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to anticipation surrounding multiple data presentations at an upcoming conference, sparking optimism within the community. Investors are discussing the potential impact of these results, particularly on the company's pipeline and market position. Some are speculating about potential M&A activity, while others focus on the potential for a significant price increase based on positive data and the company's overall value.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as community members discuss Needham initiating coverage with a buy rating and a price target of $17, coupled with an $800,000 order for drone components from Unusual Machines (UMAC). Bullish sentiment is fueled by the belief that RCAT's investment thesis is being validated within the unmanned aerial systems sector, anticipating further demand for defense-grade drones. The community speculates on potential catalysts, including government contracts and the company's position in the exploding drone market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Cara Therapeutics, Inc. (CARA) traded 10% higher on Monday afternoon after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.caratherapeutics.com/news-releases/news-release-details/cara-therapeutics-announces-1-3-reverse-stock-split-connection">announced</a> that its board of directors has approved a 1-for-3 reverse stock split of its outstanding shares of common stock.Cara’s common stock is expected to begin trading on a reverse stock split adjusted basis at the opening bell on Wednesday.The company’s common stock will trade under the new name “Tvardi Therapeutics, Inc.” and under the new symbol “TVRD” upon the closing of its merger with privately held, clinical-stage, biopharmaceutical company Tvardi Therapeutics, Inc, the company said.The two companies announced a merger in December. As per the agreement, Cara Therapeutics stockholders are expected to own about 17% of the combined company, and pre-merger Tvardi Therapeutics investors are expected to own approximately 83% of the combined company.On Tuesday evening, every three issued and outstanding shares of Cara’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the company's common stock from about 4.6 million to 1.5 million.The company said that fractional shares will not be issued as part of the reverse stock split; instead, entitled shareholders will receive a cash payment.Cara said that after the merger closes, the combined company's total outstanding common stock is expected to be approximately 9.4 million shares.On Stocktwits, retail sentiment around Cara jumped from ‘neutral’ to ‘extremely bullish’ over the past 24 hours while message volume rose from ‘extremely low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:648/153;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_14_at_1_24_29_PM_png_3d87e8bbd9.webp" alt="CARA's Sentiment Meter and Message Volume as of 1:25 p.m. ET on April 14, 2025 | Source: Stocktwits" width="648" height="153"><figcaption>CARA's Sentiment Meter and Message Volume as of 1:25 p.m. ET on April 14, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/CARA">CARA stock</a> is up by about 1% year-to-date but down by about 37% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ny-fed-survey-of-consumer-expectations/chfCQEoRbaa">NY Fed Survey Of Consumer Expectations Shows Short-Term Inflation Expectations Rose, Unemployment Worries Hit COVID-19 Levels</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Cara Therapeutics Stock Jumps 10% After Announcing 1-for-3 Reverse Stock Split: Retail Sentiment Soars

On Tuesday evening, every three issued and outstanding shares of CARA’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the company's common stock from about 4.6m to 1.5m.

Equity

On Tuesday evening, every three issued and outstanding shares of CARA’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the company's common stock from about 4.6 million to 1.5 million.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of...

CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Cara Therapeutics, Inc. (NasdaqCM: CARA) and...

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders PR...

CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick and Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of...

$HAREHOLDER ALERT: The MandA Class Action Firm Investigates the Merger of Cara Therapeutics, Inc. - CARA

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cara Therapeutics, Inc. - CARA $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cara Therapeutics, Inc...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of...

CARA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cara Therapeutics, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Cara Therapeutics, Inc. (NASDAQ: CARA) and Tvardi Therapeutics, Inc. is fair to Cara shareholders. Upon...

Shareholder Alert: Ademi LLP Investigates Whether Cara Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Ademi LLP is investigating Cara (NASDAQ: CARA) for possible breaches of fiduciary duty and other violations of law in its transaction with Tvardi. Click here to learn how to join our investigation...

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.

Cara Therapeutics Inc

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

CARA
Cara Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CARA News

CARA Cara Therapeutics Inc